Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Aptose Biosciences (APTO)
NASDAQ:APTO
Aptose Biosciences (APTO) Stock Price & Analysis
1,063 Followers
APTO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.43 - $1.55
Previous Close$0.57
Volume446.43K
Average Volume (3M)203.83K
Market Cap
$53.09M
Enterprise Value-$2.03M
Total Cash (Recent Filing)$55.39M
Total Debt (Recent Filing)$271.00K
Price to Earnings (P/E)-1.3
Beta0.72
Next Earnings
May 09, 2023EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding92,367,275
10 Day Avg. Volume124,916
30 Day Avg. Volume203,831
Standard Deviation0.24
R-Squared0.10
Alpha-0.00884
Financial Highlights & Ratios
Price to Book (P/B)1.31
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.04
Forecast
1Y Price Target
$7.50Price Target Upside1064.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Aptose Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
APTO FAQ
What was Aptose Biosciences’s price range in the past 12 months?
Aptose Biosciences lowest stock price was $0.42 and its highest was $1.55 in the past 12 months.
What is Aptose Biosciences’s market cap?
Currently, no data Available
When is Aptose Biosciences’s upcoming earnings report date?
Aptose Biosciences’s upcoming earnings report date is May 09, 2023 which is in 45 days.
How were Aptose Biosciences’s earnings last quarter?
Aptose Biosciences released its earnings results on Mar 23, 2023. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.108 by -$0.002.
Is Aptose Biosciences overvalued?
According to Wall Street analysts Aptose Biosciences’s price is currently Undervalued.
Does Aptose Biosciences pay dividends?
Aptose Biosciences does not currently pay dividends.
What is Aptose Biosciences’s EPS estimate?
Aptose Biosciences’s EPS estimate is -$0.12.
How many shares outstanding does Aptose Biosciences have?
Aptose Biosciences has 92,294,730 shares outstanding.
What happened to Aptose Biosciences’s price movement after its last earnings report?
Aptose Biosciences reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.108. Following the earnings report the stock price went up 12.281%.
Which hedge fund is a major shareholder of Aptose Biosciences?
Among the largest hedge funds holding Aptose Biosciences’s share is Carlson Capital LP. It holds Aptose Biosciences’s shares valued at 1M.
---
Aptose Biosciences Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
Aptose Biosciences
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
---
BriaCell Therapeutics
―
Portage Biotech Inc
―
Fusion Pharmaceuticals
―
Eupraxia Pharmaceuticals
―
---